Cargando…
Temporal evolution of the microbiome, immune system and epigenome with disease progression in ALS mice
Amyotrophic lateral sclerosis (ALS) is a terminal neurodegenerative disease. Genetic predisposition, epigenetic changes, aging and accumulated life-long environmental exposures are known ALS risk factors. The complex and dynamic interplay between these pathological influences plays a role in disease...
Autores principales: | Figueroa-Romero, Claudia, Guo, Kai, Murdock, Benjamin J., Paez-Colasante, Ximena, Bassis, Christine M., Mikhail, Kristen A., Raue, Kristen D., Evans, Matthew C., Taubman, Ghislaine F., McDermott, Andrew J., O'Brien, Phillipe D., Savelieff, Masha G., Hur, Junguk, Feldman, Eva L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Company of Biologists Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6906635/ https://www.ncbi.nlm.nih.gov/pubmed/31597644 http://dx.doi.org/10.1242/dmm.041947 |
Ejemplares similares
-
Cytoplasmic TDP43 Binds microRNAs: New Disease Targets in Amyotrophic Lateral Sclerosis
por: Paez-Colasante, Ximena, et al.
Publicado: (2020) -
Sex differences in insulin resistance, but not peripheral neuropathy, in a diet-induced prediabetes mouse model
por: Elzinga, Sarah E., et al.
Publicado: (2021) -
Gut microbiota in a mouse model of obesity and peripheral neuropathy associated with plasma and nerve lipidomics and nerve transcriptomics
por: Guo, Kai, et al.
Publicado: (2023) -
Untargeted metabolomics yields insight into ALS disease mechanisms
por: Goutman, Stephen A, et al.
Publicado: (2020) -
Metabolomics identifies shared lipid pathways in independent amyotrophic lateral sclerosis cohorts
por: Goutman, Stephen A, et al.
Publicado: (2022)